Efficacy and Safety of Novel Oral P2Y(12) Receptor Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction Undergoing PCI: A Systematic Review and Meta-Analysis

The efficacy and safety of novel oral P2Y(12) receptor inhibitors (prasugrel and ticagrelor) are subjects of contention in patients with ST-segment elevation myocardial infarction (STEMI) undergoing PCI, and the optimal duration of therapy remains uncertain. We searched PubMed, Embase, Cochrane Libr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jianjun, Xiang, Qian, Li, Chao, Wang, Zining, Hu, Kun, Xie, Qiufen, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578732/
https://www.ncbi.nlm.nih.gov/pubmed/28045759
http://dx.doi.org/10.1097/FJC.0000000000000459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578732/
https://www.ncbi.nlm.nih.gov/pubmed/28045759
http://dx.doi.org/10.1097/FJC.0000000000000459

Ejemplares similares